In this group, hormone receptor positivity may be of prognostic and therapeutic value since the ER and progesterone receptor (PR) are usually positive in low‐grade endometrioid carcinomas while the aggressive tumor types just listed are typically negative. The gene discussed is PGR; the disease is endometrioid adenocarcinoma.